Table 3 Clinical features of patients Associated with Low SATI

Age (years)

55.17 ± 10.55

54.06 ± 11.06

0.392

Sex, male

86(52.8%)

81(68.1%)

0.010

Etiologic cause, n (%)

Hepatitis B

81(49.7%)

59(49.6%)

0.985

Hepatitis C

6(3.7%)

6(5%)

0.576

Alcohol

11(6.7%)

17(14.3%)

0.037

Autoimmune

15(9.2%)

12(10.1%)

0.804

Others

50(30.7%)

25(21%)

0.070

Laboratory date

Hemoglobin (g/L)

87.13 ± 15.29

82.76 ± 13.72

0.014

Platelet count (10⁹/L)

87.41 ± 57.40

79.14 ± 51.45

0.213

Creatinine (µmol/L)

64.59 ± 14.95

66.38 ± 14.45

0.318

Total bilirubin (µmol/L)

18.69 ± 11.48

19.87 ± 12.18

0.406

ALT (U/L)

25.88 ± 19.11

27.81 ± 22.37

0.438

AST (U/L)

30.60 ± 16.67

32.90 ± 19.32

0.286

Serum albumin (g/L)

36.67 ± 4.56

35.40 ± 4.90

0.026

PT (s)

14.66 ± 1.94

15.05 ± 2.01

0.104

INR

1.29 ± 0.18

1.33 ± 0.18

0.173

D-dimer (g/L)

1.07 ± 1.40

1.0 ± 1.02

0.695

Child-Pugh score

6.36 ± 1.42

6.86 ± 1.56

0.005

MELD score

9.90 ± 2.36

10.35 ± 2.41

0.118

Number of endoscopic treatments

2.61 ± 0.84

2.63 ± 0.95

0.831

Number of bands

9.15 ± 3.12

9.41 ± 3.04

0.478

PVT, n (%)

58(35.6%)

34(28.6%)

0.215

Ascites, n (%)

70(42.9%)

67(56.3%)

0.027

NSBB used, n (%)

110(67.5%)

60(50.4%)

0.004

Body Composition

BMI (kg/m²)

25.03 ± 2.81

21.78 ± 8.84

< 0.001

VATI (cm²/m²)

48.42 ± 18.46

22.32 ± 12.42

< 0.001

TATI (cm²/m²)

108.19 ± 30.92

44.53 ± 18.99

< 0.001